Table 2

 Spontaneous and mutagen induced instability of the mononucleotide repeat BAT-25 and the myotonic dystrophy type 1 (CTG) and fragile X syndrome (CGG) trinucleotide repeats in multiple single cell clones of MMR proficient (SW480 and HCT116+chr.3) and deficient (HCT116 and LoVo) cell lines

TreatmentMarkerCell line
SW480LoVoHCT116HCT116+ch3
MC/TC (%)MC/TC (%)MC/TC (%)MC/TC (%)
MC/TC (%), mutant clones/total clones (percentage of mutant clones).
The difference between control and MMC treated cells is statistically significant with **p<0.01 or ***p<0.001.
ControlBAT-256/39 (15.4)25/35 (71.4)11/33 (33.3)0/40 (0.0)
CTG1/39 (2.6)0/36 (0.0)3/32 (9.4)1/40 (2.5)
CGG0/41 (0.0)6/57 (10.5)1/44 (2.3)0/40 (0.0)
MMCBAT-2515/40 (37.5)27/38 (71.0)23/40 (57.5)0/40 (0.0)
CTG18/40 (45.0)***1/40 (2.5)8/40 (20.0)3/40 (7.5)
CGG21/39 (53.8)***2/40 (5.0)10/40 (25.0)**0/40 (0.0)